Novartis shared today the difficult news that they are stopping the VIBRANT-HD study of Branaplam, after some participants devoloping side effects.

Even if this news can be disappointing, the HD Community will keep positive and hope the remaining trials and tests can bring some good news.

Categorii: Știri

0 comentarii

Lasă un răspuns

Avatar placeholder

Adresa ta de email nu va fi publicată. Câmpurile obligatorii sunt marcate cu *

ro_RORomanian